首页 > 最新文献

Life metabolism最新文献

英文 中文
Manganese therapy for dyslipidemia and plaque reversal in murine models 锰治疗小鼠血脂异常和斑块逆转
Pub Date : 2023-10-26 DOI: 10.1093/lifemeta/load040
Yawei Wang, Xin Feng, Wenjing Zhou, Runze Huang, Yating Hu, Hui Hui, Jie Tian, Xiao Wang, Xiao-Wei Chen
{"title":"Manganese therapy for dyslipidemia and plaque reversal in murine models","authors":"Yawei Wang, Xin Feng, Wenjing Zhou, Runze Huang, Yating Hu, Hui Hui, Jie Tian, Xiao Wang, Xiao-Wei Chen","doi":"10.1093/lifemeta/load040","DOIUrl":"https://doi.org/10.1093/lifemeta/load040","url":null,"abstract":"","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134908080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
DIESL fuels a DGAT-independent triglyceride synthesis pathway 柴油为不依赖dgat的甘油三酯合成途径提供燃料
Pub Date : 2023-10-05 DOI: 10.1093/lifemeta/load039
Lauren F Uchiyama, Peter Tontonoz
Alternative triglyceride (TG) synthesis pathways have yet to be identified in mammalian cells. In a recent article published in Nature, Brummelkamp and colleagues reported the acyltransferase TMEM68/DIESL synthesizes TG in the absence of the canonical enzymes diacylglycerol acyltransferase 1 (DGAT1) and DGAT2.
在哺乳动物细胞中,甘油三酯(TG)的合成途径尚未确定。在最近发表在《自然》杂志上的一篇文章中,Brummelkamp及其同事报道了酰基转移酶TMEM68/ diesel在缺少典型酶二酰基甘油酰基转移酶1 (DGAT1)和DGAT2的情况下合成TG。
{"title":"DIESL fuels a DGAT-independent triglyceride synthesis pathway","authors":"Lauren F Uchiyama, Peter Tontonoz","doi":"10.1093/lifemeta/load039","DOIUrl":"https://doi.org/10.1093/lifemeta/load039","url":null,"abstract":"Alternative triglyceride (TG) synthesis pathways have yet to be identified in mammalian cells. In a recent article published in Nature, Brummelkamp and colleagues reported the acyltransferase TMEM68/DIESL synthesizes TG in the absence of the canonical enzymes diacylglycerol acyltransferase 1 (DGAT1) and DGAT2.","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135483097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitochondrial YBX1 promotes cancer cell metastasis by inhibiting pyruvate uptake 线粒体YBX1通过抑制丙酮酸摄取促进癌细胞转移
Pub Date : 2023-09-27 DOI: 10.1093/lifemeta/load038
Huan Chen, Ting Ling, Di Chen, Wenjuan Liu, Huan Qi, Tian Xia, Xiaolong Liu, Wen Wang, Xin Guo, Wuxiyar Otkur, Fangjun Wang, Zhaochao Xu, Jean-Claude Martinou, Hai-long Piao
Abstract Pyruvate is an essential fuel for maintaining the tricarboxylic acid (TCA) cycle in the mitochondria. However, the precise molecular mechanism of pyruvate uptake by mitochondrial pyruvate carrier (MPC) is largely unknown. Here, we report that the DNA/RNA-binding protein Y-box binding protein 1 (YBX1) is localized to the mitochondrial inter-membrane space (IMS) by its C-terminal domain (CTD) in cancer cells. In mitochondria, YBX1 inhibits pyruvate uptake by associating with MPC1/2, thereby suppressing pyruvate-dependent TCA cycle flux. This association, in turn, promotes MPC-mediated glutaminolysis and histone lactylation. Our findings reveal that the YBX1-MPC axis exhibits a positive correlation with metastatic potential, while does not affect cell proliferation in both cultured cells and tumor xenografts. Therefore, the restricted pyruvate uptake into mitochondria potentially represents a hallmark of metastatic capacity, suggesting that the YBX1-MPC axis is a therapeutic target for combating cancer metastasis.
丙酮酸是维持线粒体中三羧酸(TCA)循环的必需燃料。然而,线粒体丙酮酸载体(MPC)摄取丙酮酸的确切分子机制在很大程度上是未知的。在这里,我们报道了DNA/ rna结合蛋白Y-box结合蛋白1 (YBX1)在癌细胞中通过其c -末端结构域(CTD)定位于线粒体膜间隙(IMS)。在线粒体中,YBX1通过与MPC1/2结合抑制丙酮酸摄取,从而抑制丙酮酸依赖的TCA循环通量。这种关联反过来促进mpc介导的谷氨酰胺水解和组蛋白乳酸化。我们的研究结果表明,YBX1-MPC轴与转移潜能呈正相关,而不影响培养细胞和肿瘤移植细胞的增殖。因此,限制丙酮酸进入线粒体可能代表了转移能力的标志,这表明YBX1-MPC轴是对抗癌症转移的治疗靶点。
{"title":"Mitochondrial YBX1 promotes cancer cell metastasis by inhibiting pyruvate uptake","authors":"Huan Chen, Ting Ling, Di Chen, Wenjuan Liu, Huan Qi, Tian Xia, Xiaolong Liu, Wen Wang, Xin Guo, Wuxiyar Otkur, Fangjun Wang, Zhaochao Xu, Jean-Claude Martinou, Hai-long Piao","doi":"10.1093/lifemeta/load038","DOIUrl":"https://doi.org/10.1093/lifemeta/load038","url":null,"abstract":"Abstract Pyruvate is an essential fuel for maintaining the tricarboxylic acid (TCA) cycle in the mitochondria. However, the precise molecular mechanism of pyruvate uptake by mitochondrial pyruvate carrier (MPC) is largely unknown. Here, we report that the DNA/RNA-binding protein Y-box binding protein 1 (YBX1) is localized to the mitochondrial inter-membrane space (IMS) by its C-terminal domain (CTD) in cancer cells. In mitochondria, YBX1 inhibits pyruvate uptake by associating with MPC1/2, thereby suppressing pyruvate-dependent TCA cycle flux. This association, in turn, promotes MPC-mediated glutaminolysis and histone lactylation. Our findings reveal that the YBX1-MPC axis exhibits a positive correlation with metastatic potential, while does not affect cell proliferation in both cultured cells and tumor xenografts. Therefore, the restricted pyruvate uptake into mitochondria potentially represents a hallmark of metastatic capacity, suggesting that the YBX1-MPC axis is a therapeutic target for combating cancer metastasis.","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135579139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
7-Dehydrocholesterol protects against circadian disruption and experimental colitis: potential role of RORα/γ 7-脱氢胆固醇可预防昼夜节律紊乱和实验性结肠炎:rora /γ的潜在作用
Pub Date : 2023-09-19 DOI: 10.1093/lifemeta/load034
Feng Li, Shubin Lin, Zhiyi Tan, Yanqing Pang, Shuai Wang
{"title":"7-Dehydrocholesterol protects against circadian disruption and experimental colitis: potential role of RORα/γ","authors":"Feng Li, Shubin Lin, Zhiyi Tan, Yanqing Pang, Shuai Wang","doi":"10.1093/lifemeta/load034","DOIUrl":"https://doi.org/10.1093/lifemeta/load034","url":null,"abstract":"","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135060546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcript profile of CLSTN3B gene in human white adipose tissue is associated with obesity and mitochondrial gene program 人白色脂肪组织CLSTN3B基因转录谱与肥胖和线粒体基因程序相关
Pub Date : 2023-09-14 DOI: 10.1093/lifemeta/load037
Ningning Bai, Xuhong Lu, Yansu Wang, Xiaoya Li, Rong Zhang, Haoyong Yu, Cheng Hu, Xiaojing Ma, Yuqian Bao, Ying Yang
{"title":"Transcript profile of <i>CLSTN3B</i> gene in human white adipose tissue is associated with obesity and mitochondrial gene program","authors":"Ningning Bai, Xuhong Lu, Yansu Wang, Xiaoya Li, Rong Zhang, Haoyong Yu, Cheng Hu, Xiaojing Ma, Yuqian Bao, Ying Yang","doi":"10.1093/lifemeta/load037","DOIUrl":"https://doi.org/10.1093/lifemeta/load037","url":null,"abstract":"","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135552845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blockade of Arf1-mediated lipid metabolism in cancers promotes tumor infiltration of cytotoxic T cells via the LPE-PPARγ-NF-κB-CCL5 pathway 阻断肿瘤中arf1介导的脂质代谢可通过LPE-PPARγ-NF-κB-CCL5途径促进细胞毒性T细胞的肿瘤浸润
Pub Date : 2023-09-06 DOI: 10.1093/lifemeta/load036
Na Wang, Tiange Yao, Chenfei Luo, Ling Sun, Yuetong Wang, Steven X Hou
Abstract Tumor immunotherapy has achieved breakthroughs in a variety of tumors. However, the systemic absence of T cells in tumors and immunosuppressive tumor microenvironment so far limits the efficacy of immunotherapy to a small population of patients. Therefore, novel agents to increase T-cell tumor infiltration are urgently needed in the clinic. We recently found that inhibition of the ADP-ribosylation factor 1 (Arf1)-mediated lipid metabolism not only kills cancer stem cells (CSCs) but also elicits an anti-tumor immune response. In this study, we revealed a mechanism that targeting Arf1 promotes the infiltration of cytotoxic T lymphocytes (CTLs) into tumors through the C-C chemokine ligand 5 (CCL5)- C-C chemokine receptor type 5 (CCR5) pathway. We found that blockage of Arf1 induces the production of the unsaturated fatty acid (PE 18:1) that binds and sequestrates peroxisome proliferator-­activated receptor-γ (PPARγ) from the PPARγ-nuclear factor-κB (NF-κB) cytoplasmic complex. The released NF-κB was then phosphorylated and translocated into the nucleus to regulate the transcription of chemokine CCL5. CCL5 promoted infiltration of CTLs for tumor regression. Furthermore, the combination of the Arf1 inhibitor and programmed cell death protein 1 (PD-1) blockade induced an even stronger anti-tumor immunity. Therefore, targeting Arf1 represents a novel anti-tumor immune approach by provoking T-cell tumor infiltration and may provide a new strategy for tumor immunotherapy.
肿瘤免疫治疗在多种肿瘤中取得了突破性进展。然而,到目前为止,肿瘤中T细胞的系统性缺失和免疫抑制肿瘤微环境限制了免疫治疗对一小部分患者的疗效。因此,临床迫切需要新的增加t细胞肿瘤浸润的药物。我们最近发现,抑制adp -核糖基化因子1 (Arf1)介导的脂质代谢不仅可以杀死癌症干细胞(CSCs),还可以引发抗肿瘤免疫反应。本研究揭示了靶向Arf1通过C-C趋化因子配体5 (CCL5)- C-C趋化因子受体5型(CCR5)通路促进细胞毒性T淋巴细胞(ctl)向肿瘤浸润的机制。我们发现Arf1的阻断诱导不饱和脂肪酸(PE 18:1)的产生,该不饱和脂肪酸结合并隔离PPARγ-核因子-κB (NF-κB)细胞质复合物中的过氧化物酶体增殖物激活受体-γ (PPARγ)。释放的NF-κB随后被磷酸化并转运到细胞核中调节趋化因子CCL5的转录。CCL5促进ctl浸润,促进肿瘤消退。此外,Arf1抑制剂和程序性细胞死亡蛋白1 (PD-1)抑制剂联合使用可诱导更强的抗肿瘤免疫。因此,以Arf1为靶点,通过诱导t细胞肿瘤浸润,是一种新的抗肿瘤免疫途径,可能为肿瘤免疫治疗提供新的策略。
{"title":"Blockade of Arf1-mediated lipid metabolism in cancers promotes tumor infiltration of cytotoxic T cells via the LPE-PPARγ-NF-κB-CCL5 pathway","authors":"Na Wang, Tiange Yao, Chenfei Luo, Ling Sun, Yuetong Wang, Steven X Hou","doi":"10.1093/lifemeta/load036","DOIUrl":"https://doi.org/10.1093/lifemeta/load036","url":null,"abstract":"Abstract Tumor immunotherapy has achieved breakthroughs in a variety of tumors. However, the systemic absence of T cells in tumors and immunosuppressive tumor microenvironment so far limits the efficacy of immunotherapy to a small population of patients. Therefore, novel agents to increase T-cell tumor infiltration are urgently needed in the clinic. We recently found that inhibition of the ADP-ribosylation factor 1 (Arf1)-mediated lipid metabolism not only kills cancer stem cells (CSCs) but also elicits an anti-tumor immune response. In this study, we revealed a mechanism that targeting Arf1 promotes the infiltration of cytotoxic T lymphocytes (CTLs) into tumors through the C-C chemokine ligand 5 (CCL5)- C-C chemokine receptor type 5 (CCR5) pathway. We found that blockage of Arf1 induces the production of the unsaturated fatty acid (PE 18:1) that binds and sequestrates peroxisome proliferator-­activated receptor-γ (PPARγ) from the PPARγ-nuclear factor-κB (NF-κB) cytoplasmic complex. The released NF-κB was then phosphorylated and translocated into the nucleus to regulate the transcription of chemokine CCL5. CCL5 promoted infiltration of CTLs for tumor regression. Furthermore, the combination of the Arf1 inhibitor and programmed cell death protein 1 (PD-1) blockade induced an even stronger anti-tumor immunity. Therefore, targeting Arf1 represents a novel anti-tumor immune approach by provoking T-cell tumor infiltration and may provide a new strategy for tumor immunotherapy.","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135203505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Life Metabolism Travel Prize of 2023 2023年生命代谢旅游奖
Pub Date : 2023-09-05 DOI: 10.1093/lifemeta/load035
Xiaolei Liu
{"title":"Life Metabolism Travel Prize of 2023","authors":"Xiaolei Liu","doi":"10.1093/lifemeta/load035","DOIUrl":"https://doi.org/10.1093/lifemeta/load035","url":null,"abstract":"","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135319038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracellular matrix remodelling in obesity and metabolic disorders. 肥胖和代谢紊乱中的细胞外基质重塑。
Pub Date : 2023-08-01 Epub Date: 2023-05-26 DOI: 10.1093/lifemeta/load021
Vishal Musale, David H Wasserman, Li Kang

Obesity causes extracellular matrix (ECM) remodelling which can develop into serious pathology and fibrosis, having metabolic effects in insulin-sensitive tissues. The ECM components may be increased in response to overnutrition. This review will focus on specific obesity-associated molecular and pathophysiological mechanisms of ECM remodelling and the impact of specific interactions on tissue metabolism. In obesity, complex network of signalling molecules such as cytokines and growth factors have been implicated in fibrosis. Increased ECM deposition contributes to the pathogenesis of insulin resistance at least in part through activation of cell surface integrin receptors and CD44 signalling cascades. These cell surface receptors transmit signals to the cell adhesome which orchestrates an intracellular response that adapts to the extracellular environment. Matrix proteins, glycoproteins, and polysaccharides interact through ligand-specific cell surface receptors that interact with the cytosolic adhesion proteins to elicit specific actions. Cell adhesion proteins may have catalytic activity or serve as scaffolds. The vast number of cell surface receptors and the complexity of the cell adhesome have made study of their roles challenging in health and disease. Further complicating the role of ECM-cell receptor interactions is the variation between cell types. This review will focus on recent insights gained from studies of two highly conserved, ubiquitously axes and how they contribute to insulin resistance and metabolic dysfunction in obesity. These are the collagen-integrin receptor-IPP (ILK-PINCH-Parvin) axis and the hyaluronan-CD44 interaction. We speculate that targeting ECM components or their receptor-mediated cell signalling may provide novel insights into the treatment of obesity-associated cardiometabolic complications.

肥胖会导致细胞外基质(ECM)重塑,进而发展成严重的病理和纤维化,对胰岛素敏感组织的代谢产生影响。ECM 成分可能会因营养过剩而增加。本综述将重点讨论与肥胖相关的 ECM 重塑的特定分子和病理生理机制,以及特定相互作用对组织代谢的影响。在肥胖症中,细胞因子和生长因子等信号分子的复杂网络与纤维化有关。ECM 沉积的增加至少部分是通过激活细胞表面整合素受体和 CD44 信号级联导致胰岛素抵抗的发病机制。这些细胞表面受体向细胞粘附体传递信号,细胞粘附体则协调细胞内的反应,以适应细胞外环境。基质蛋白、糖蛋白和多糖通过配体特异性细胞表面受体相互作用,这些细胞表面受体与细胞膜粘附蛋白相互作用,从而激发特定的作用。细胞粘附蛋白可能具有催化活性,也可能充当支架。细胞表面受体的数量之多和细胞粘附体的复杂性使得研究它们在健康和疾病中的作用变得十分困难。细胞类型之间的差异使 ECM-细胞受体相互作用的作用更加复杂。本综述将重点介绍最近对两个高度保守、无处不在的轴的研究结果,以及它们如何导致肥胖症的胰岛素抵抗和代谢功能障碍。这就是胶原蛋白-整合素受体-IPP(ILK-PINCH-Parvin)轴和透明质酸-CD44相互作用。我们推测,针对 ECM 成分或其受体介导的细胞信号,可能会为治疗肥胖相关的心脏代谢并发症提供新的见解。
{"title":"Extracellular matrix remodelling in obesity and metabolic disorders.","authors":"Vishal Musale, David H Wasserman, Li Kang","doi":"10.1093/lifemeta/load021","DOIUrl":"10.1093/lifemeta/load021","url":null,"abstract":"<p><p>Obesity causes extracellular matrix (ECM) remodelling which can develop into serious pathology and fibrosis, having metabolic effects in insulin-sensitive tissues. The ECM components may be increased in response to overnutrition. This review will focus on specific obesity-associated molecular and pathophysiological mechanisms of ECM remodelling and the impact of specific interactions on tissue metabolism. In obesity, complex network of signalling molecules such as cytokines and growth factors have been implicated in fibrosis. Increased ECM deposition contributes to the pathogenesis of insulin resistance at least in part through activation of cell surface integrin receptors and CD44 signalling cascades. These cell surface receptors transmit signals to the cell adhesome which orchestrates an intracellular response that adapts to the extracellular environment. Matrix proteins, glycoproteins, and polysaccharides interact through ligand-specific cell surface receptors that interact with the cytosolic adhesion proteins to elicit specific actions. Cell adhesion proteins may have catalytic activity or serve as scaffolds. The vast number of cell surface receptors and the complexity of the cell adhesome have made study of their roles challenging in health and disease. Further complicating the role of ECM-cell receptor interactions is the variation between cell types. This review will focus on recent insights gained from studies of two highly conserved, ubiquitously axes and how they contribute to insulin resistance and metabolic dysfunction in obesity. These are the collagen-integrin receptor-IPP (ILK-PINCH-Parvin) axis and the hyaluronan-CD44 interaction. We speculate that targeting ECM components or their receptor-mediated cell signalling may provide novel insights into the treatment of obesity-associated cardiometabolic complications.</p>","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299575/pdf/nihms-1904676.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10275103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lactate as a regulator of iron homeostasis 乳酸作为铁体内平衡的调节剂
Pub Date : 2023-07-27 DOI: 10.1093/lifemeta/load033
G. Anderson, D. Frazer
The key metabolic intermediate lactate can increase expression of the liver-derived peptide hepcidin, the central regulator of body iron homeostasis. A new paper by Liu et al. shows that lactate achieves this by binding to and activating soluble adenylyl cyclase, thereby increasing cellular cyclic adenosine monophosphate (cAMP) (cAMP) and enhancing signaling through the bone morphogenetic protein (BMP) pathway to modulate hepcidin expression.
关键的代谢中间产物乳酸可以增加肝源肽hepcidin的表达,hepcidin是体内铁稳态的中央调节剂。Liu等人的一篇新论文表明,乳酸通过结合并激活可溶性腺苷酸环化酶,从而增加细胞环磷酸腺苷(cAMP),并通过骨形态发生蛋白(BMP)途径增强信号传导调节hepcidin的表达。
{"title":"Lactate as a regulator of iron homeostasis","authors":"G. Anderson, D. Frazer","doi":"10.1093/lifemeta/load033","DOIUrl":"https://doi.org/10.1093/lifemeta/load033","url":null,"abstract":"\u0000 The key metabolic intermediate lactate can increase expression of the liver-derived peptide hepcidin, the central regulator of body iron homeostasis. A new paper by Liu et al. shows that lactate achieves this by binding to and activating soluble adenylyl cyclase, thereby increasing cellular cyclic adenosine monophosphate (cAMP) (cAMP) and enhancing signaling through the bone morphogenetic protein (BMP) pathway to modulate hepcidin expression.","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45220675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glucokinase and glucokinase activator 葡萄糖激酶和葡萄糖激酶激活剂
Pub Date : 2023-07-13 DOI: 10.1093/lifemeta/load031
Chang Li, Y. Zhang, Li Chen, Xiaoying Li
Glucokinase (GK) plays a pivotal role in glucose homeostasis as the glucose sensor in the pancreas and liver. Loss of function of GK results in hyperglycemia, and gain of function causes congenital hyperinsulinemic hypoglycemia. We speculate that the progressive loss of GK at both mRNA and protein levels in the islets and liver would be the key mechanism for type 2 diabetes pathogenesis. The development of GK activator (GKA) as an anti-diabetic drug has been endeavored for several decades. The failure of the early development of GKAs is due to the limitation of understanding the mode of GKA action. The success of dorzagliatin in the treatment of type 2 diabetes has brought new hope for GK in setting a good model for repairing the underlying defects in the pancreatic islets and liver of T2D patients.
葡萄糖激酶(GK)作为胰腺和肝脏中的葡萄糖传感器,在葡萄糖稳态中起着关键作用。GK功能丧失导致高血糖,功能获得导致先天性高胰岛素性低血糖。我们推测,胰岛和肝脏中GK mRNA和蛋白水平的逐渐丧失可能是2型糖尿病发病的关键机制。GK激活剂(GKA)作为一种抗糖尿病药物的开发已经进行了几十年的努力。GKA早期发展的失败是由于对GKA作用模式的认识有限。dorzagliatin治疗2型糖尿病的成功,为GK为T2D患者胰岛和肝脏潜在缺陷的修复建立良好的模型带来了新的希望。
{"title":"Glucokinase and glucokinase activator","authors":"Chang Li, Y. Zhang, Li Chen, Xiaoying Li","doi":"10.1093/lifemeta/load031","DOIUrl":"https://doi.org/10.1093/lifemeta/load031","url":null,"abstract":"\u0000 Glucokinase (GK) plays a pivotal role in glucose homeostasis as the glucose sensor in the pancreas and liver. Loss of function of GK results in hyperglycemia, and gain of function causes congenital hyperinsulinemic hypoglycemia. We speculate that the progressive loss of GK at both mRNA and protein levels in the islets and liver would be the key mechanism for type 2 diabetes pathogenesis. The development of GK activator (GKA) as an anti-diabetic drug has been endeavored for several decades. The failure of the early development of GKAs is due to the limitation of understanding the mode of GKA action. The success of dorzagliatin in the treatment of type 2 diabetes has brought new hope for GK in setting a good model for repairing the underlying defects in the pancreatic islets and liver of T2D patients.","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47036801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Life metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1